Trevi Therapeutics Stock Investor Sentiment
| TRVI Stock | USD 2.88 0.04 1.37% |
Under 67% of Trevi Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Trevi Therapeutics stock suggests that many investors are alarmed at this time. Trevi Therapeutics' investing sentiment shows overall attitude of investors towards Trevi Therapeutics.
Trevi |
Trevi Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Trevi Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Trevi Therapeutics that are available to investors today. That information is available publicly through Trevi media outlets and privately through word of mouth or via Trevi internal channels. However, regardless of the origin, that massive amount of Trevi data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Trevi Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Trevi Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Trevi Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Trevi Therapeutics alpha.
Trevi Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 3863 shares by Jennifer Good of Trevi Therapeutics at 1.43 subject to Rule 16b-3 | 09/03/2024 |
2 | Disposition of 4219 shares by Jennifer Good of Trevi Therapeutics at 1.43 subject to Rule 16b-3 | 09/06/2024 |
3 | Disposition of 1840 shares by Jennifer Good of Trevi Therapeutics at 1.43 subject to Rule 16b-3 | 09/09/2024 |
4 | Trevi Therapeutics, Inc. Given Average Rating of Buy by Analysts - MarketBeat | 09/24/2024 |
5 | Acquisition by James Cassella of 400000 shares of Trevi Therapeutics at 3.34 subject to Rule 16b-3 | 09/30/2024 |
6 | Trevi Therapeutics Provides Update on Haduvios Clinical Development Program | 10/03/2024 |
7 | Trevi Therapeutics Inc Q2 2024 Earnings Call Highlights Navigating Financial Challenges ... | 10/09/2024 |
8 | Trevi Therapeutics Given Buy Rating at HC Wainwright | 10/22/2024 |
9 | Trevi Therapeutics EPS of -0.13 misses by 0.02 | 11/06/2024 |
10 | Trevi Therapeutics Inc Q3 2024 Earnings Call Highlights Navigating Increased Losses and ... | 11/07/2024 |
11 | Trevi Therapeutics, Inc. Receives 7.43 Average PT from Brokerages - MarketBeat | 11/13/2024 |
12 | Landscape Capital Management L.L.C. Sells 180,717 Shares of Trevi Therapeutics, Inc. | 11/22/2024 |
Complementary Tools for Trevi Stock analysis
When running Trevi Therapeutics' price analysis, check to measure Trevi Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trevi Therapeutics is operating at the current time. Most of Trevi Therapeutics' value examination focuses on studying past and present price action to predict the probability of Trevi Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trevi Therapeutics' price. Additionally, you may evaluate how the addition of Trevi Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |